Megafine

Megafine Pharma is a leading manufacturer of pharmaceutical APIs and intermediates offering integrated CDMO/CMO services including process development, scale-up, commercial manufacturing, and regulatory support. Our portfolio includes Apixaban, Rivaroxaban, Mirtazapine, Cinacalcet HCl, Desvenlafaxine Succinate, Mirabegron, Vildagliptin, Quetiapine Hemifumarate, Donepezil HCl, Memantine HCl, Solifenacin Succinate, Bosentan Monohydrate, Ambrisentan, Venlafaxine HCl, Teriflunomide, and Vortioxetine HBr. Our facilities operate with US FDA, EDQM, PMDA, ANVISA, WHO-GMP, and CDSCO compliant quality systems serving regulated and semi-regulated markets globally. Products under development include Cariprazine HCl, Fezolinetant, Finerenone, Resmetirom, Vericiguat, Vibegron, and Xanomeline Tartrate.